Ocugen, Inc. (OCGN) vs YD Bio Limited (YDES)

Ocugen, Inc. and YD Bio Limited are both Biotechnology companies. Ocugen, Inc. and YD Bio Limited are of similar size ($339.1M and $332.3M).

Metric	OCGN	YDES	Biotechnology median
P/E	n/m	—	7.88
P/S	75.43	—	11.47
P/B	n/m	—	2.52
Price to free cash flow	n/m	—	21.16
EV/EBITDA	n/m	—	0.74
EV/Sales	53.96	—	10.73
Earnings yield	(25.49%)	—	(28.84%)
Free cash flow yield	(17.66%)	—	(23.03%)

Metric	OCGN	YDES	Biotechnology median
Gross margin	100.00%	—	65.16%
Operating margin	(1,504.43%)	—	0.00%
Net margin	(1,786.27%)	—	0.00%
Free cash flow margin	(1,332.36%)	—	0.00%
Return on equity	1,211.66%	—	(57.72%)
Return on assets	(92.03%)	—	(49.22%)
Return on invested capital	0.00%	—	0.00%

Metric	OCGN	YDES	Biotechnology median
Revenue growth (TTM)	(3.66%)	—	5.64%
EPS growth (last fiscal year)	(15.00%)	—	—
Revenue growth, 5-year CAGR	—	—	8.40%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	OCGN	YDES	Biotechnology median
Debt to equity	(0.11)	—	0.00
Current ratio	0.80	—	4.73
Net debt to EBITDA	(0.17)	—	0.96

Metric	OCGN	YDES	Biotechnology median
Dividend yield	—	—	2.10%
Payout ratio	0.00	—	0.00

Metric	OCGN	YDES	Biotechnology median
Market cap	339.11m	332.25m	162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack